Effect on coagulation and hemorrhage of fluids administered during surgery in order to minimize loss of blood.

Effect of Human Albumin versus crystalloid on coagulation competence during elective urologic surgery.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-005350-29-DK

Enrollment

Registered

2014-02-12

Start date

2014-02-14

Completion date

Unknown

Last updated

2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation and loss of blood MedDRA version: 16.1 Level: LLT Classification code 10000122 Term: Abnormal coagulation profile System Organ Class: 100000004848

Interventions

Trade Name: Ringer-lactate Product Name: Lactated Ringer Product Code: 3635 Pharmaceutical Form: Infusion INN or Proposed INN: Ringer-lactate Other descriptive name: SODIUM LACTATE Concentration unit:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Without anticoagulative mediation for at least 5 days and planned removal of the urine bladder. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: No intracerebral hemorrhage, no manifest kidney-hepatic or heart disease.

Design outcomes

Primary

Measure	Time frame
Main Objective: Coagulation competence;Secondary Objective: Loss of blood;Primary end point(s): Coagulation competence;Timepoint(s) of evaluation of this end point: 24 hours	—

Secondary

Measure	Time frame
Secondary end point(s): Volume of hemorrhage;Timepoint(s) of evaluation of this end point: 5 hours	—

Countries

Denmark

Contacts

Public ContactK C Rasmussen

Rigshospitalry

dockcr@yahoo.com004535458128

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026